Short vs. long amoxicillin treatment for childhood pneumonia
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study compares whether 3 days or 5 days of amoxicillin (an antibiotic) works better for treating bacterial pneumonia in young children. It aims to find the shortest safe treatment that cures the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 3 months and 5 years old
- Recent fever (temperature ≥100.4°F) or fever reported by caregiver within the last 2 days
- Cough observed or reported within the last 3 days
- Chest X-ray showing pneumonia (dense spot in the lung without certain patterns)
- Blood tests showing signs of infection (C-reactive protein ≥40, white blood cells ≥12,200)
- Breathing is faster than normal for child's age (≥50 breaths/min if under 1 year; ≥40 breaths/min if 1-5 years)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether children with a common type of pneumonia can safely stop antibiotics earlier than usual. It is for children who are otherwise healthy and have a mild pneumonia that can be treated at home.
This trial tests whether twice-daily amoxicillin helps treat non-severe pneumonia in children. It may be a good option if your child has a mild form confirmed by symptoms and a chest X-ray.
This trial tests whether an oral antibiotic (amoxicillin) works as well as an IV antibiotic (ceftriaxone) for children with mild pneumonia. It may help avoid the need for an IV line.
This trial is testing how many days of antibiotics are best for adults with pneumonia who are treated by their regular doctor (not in a hospital). The goal is to find the shortest effective treatment to reduce side effects and antibiotic resistance.
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.